Skye Bioscience, Inc. Operating Lease, Liability, Current
Skye Bioscience, Inc. (SKYE) had Operating Lease, Liability, Current of $35.70 thousand as of 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Notes › Leases
us-gaap:OperatingLeaseLiabilityCurrent · last filed 2026-08-14
- 2026-06-30: Operating Lease, Liability, Current $35.70K.
- 2026-03-31: Operating Lease, Liability, Current $60.98K.
- 2025-12-31: Operating Lease, Liability, Current $189.65K.
- 2025-09-30: Operating Lease, Liability, Current $201.64K.
| Period end | Operating Lease, Liability, Current |
|---|---|
| 2026-06-30 | $35.70K 10-Q · filed 2026-08-14 |
| 2026-03-31 | $60.98K 10-Q · filed 2026-05-11 |
| 2025-12-31 | $189.65K 10-Q · filed 2026-08-14 |
| 2025-09-30 | $201.64K 10-Q · filed 2025-11-10 |
| 2025-06-30 | $195.05K 10-Q · filed 2025-08-07 |
| 2025-03-31 | $188.65K 10-Q · filed 2025-05-08 |
| 2024-12-31 | $182.43K 10-K · filed 2026-03-10 |
| 2024-09-30 | $82.93K 10-Q · filed 2024-11-07 |
| 2024-06-30 | $79.17K 10-Q · filed 2024-08-09 |
| 2024-03-31 | $75.53K 10-Q · filed 2024-05-10 |
| 2023-12-31 | $72.04K 10-K · filed 2025-03-20 |
| 2023-09-30 | $68.68K 10-Q · filed 2023-11-14 |
| 2023-06-30 | $65.45K 10-Q · filed 2023-08-07 |
| 2023-03-31 | $81.32K 10-Q · filed 2023-05-12 |
| 2022-12-31 | $78.70K 10-K · filed 2024-03-22 |
| 2022-09-30 | $92.36K 10-Q · filed 2022-11-14 |
| 2022-06-30 | $88.93K 10-Q · filed 2022-08-15 |
| 2022-03-31 | $85.60K 10-Q · filed 2022-05-06 |
| 2021-12-31 | $82.37K 10-K · filed 2023-03-31 |
| 2021-09-30 | $63.58K 10-Q · filed 2021-11-10 |
| 2020-12-31 | $0.00 10-K · filed 2022-03-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CalciMedica, Inc. (CALC) | United States | $0.061B | -1.42 |
| TALPHERA, INC. (TLPH) | United States | $0.060B | |
| Boundless Bio, Inc. (BOLD) | United States | $0.059B | -0.88 |
| NOMAD POWER SOLUTIONS, INC. (NMAD) | United States | $0.058B | |
| Rein Therapeutics, Inc. (RNTX) | United States | $0.063B | -1.76 |
| HYPERION DEFI, INC. (HYPD) | United States | $0.065B | |
| Annovis Bio, Inc. (ANVS) | United States | $0.056B | -1.58 |
| XBiotech Inc. (XBIT) | United States | $0.066B | -1.56 |
| HERON THERAPEUTICS, INC. /DE/ (HRTX) | United States | $0.055B | -2.38 |
| Clene Inc. (CLNN) | United States | $0.054B | -1.99 |